Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Researchers are already testing triple-agonist drugs, such as retatrutide, which target GLP-1, GIP and glucagon receptors
However, extremely rapid weight loss is not always necessary for meaningful results
The $285 million payment includes an upfront fee plus development and regulatory milestone payments for the lead program, plus royalties
At 5,000 mcg/mL that is 0.4 mL, which equals 40 units on a U-100 syringe
How obese do you have to be to get tirzepatide
US$ 20.26
US$ 24.01
US$ 23.54
US$ 21.47
US$ 23.27
